Excess Risk of Death from Intensive Care Unit--Acquired Nosocomial Bloodstream Infections: A Reappraisal
- 15 April 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (8) , 1118-1126
- https://doi.org/10.1086/500318
Abstract
Overall rates of bloodstream infection (BSI) are often used as quality indicators in intensive care units (ICUs). We investigated whether ICU-acquired BSI increased mortality (by > or = 10%) after adjustment for severity of infection at ICU admission and during the pre-BSI stay. We conducted a matched, risk-adjusted (1:n), exposed-unexposed study of patients with stays longer than 72 h in 12 ICUs randomly selected from the Outcomerea database. Patients with BSI after the third ICU day (exposed group) were matched on the basis of risk-exposure time and mortality predicted at admission using the Three-Day Recalibrated ICU Outcome (TRIO) score to patients without BSI (unexposed group). Severity was assessed daily using the Logistic Organ Dysfunction (LOD) score. Of 3247 patients with ICU stays of >3 days, 232 experienced BSI by day 30 (incidence, 6.8 cases per 100 admissions); among them, 226 patients were matched to 1023 unexposed patients. Crude hospital mortality was 61.5% among exposed and 36.7% among unexposed patients (P<.0001). Attributable mortality was 24.8%. The only variable associated with both BSI and hospital mortality was the LOD score determined 4 days before onset of BSI (odds ratio [OR], 1.10; 95% confidence interval [CI], 1.03-1.16; P = .0025). The adjusted OR for hospital mortality among exposed patients (OR, 3.20; 95% CI, 2.30-4.43) decreased when the LOD score determined 4 days before onset of BSI was taken into account (OR, 3.02; 95% CI, 2.17-4.22; P<.0001). The estimated risk of death from BSI varied considerably according to the source and resistance of organisms, time to onset, and appropriateness of treatment. When adjusted for risk-exposure time and severity at admission and during the ICU stay, BSI was associated with a 3-fold increase in mortality, but considerable variation occurred across BSI subgroups. Focusing on BSI subgroups may be valuable for assessing quality of care in ICUs.Keywords
This publication has 45 references indexed in Scilit:
- Absence of Excess Mortality in Critically Ill Patients With Nosocomial Escherichia coli BacteremiaInfection Control & Hospital Epidemiology, 2003
- Evaluation of Outcome in Critically Ill Patients With Nosocomial Enterobacter BacteremiaChest, 2003
- Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort studyIntensive Care Medicine, 2003
- Reappraisal of attributable mortality in critically ill patients with nosocomial bacteraemia involving Pseudomonas aeruginosaJournal of Hospital Infection, 2003
- Clinical Impact of Nosocomial Klebsiella Bacteremia in Critically Ill PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Outcomes of Primary and Catheter-related BacteremiaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- The Attributable Mortality and Costs of Primary Nosocomial Bloodstream Infections in the Intensive Care UnitAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Mortality probability models for patients in the intensive care unit for 48 or 72 hoursCritical Care Medicine, 1994
- Nosocomial Bloodstream Infection in Critically III PatientsJAMA, 1994
- A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter StudyJAMA, 1993